Venezuela Hospitals Choose Spacelabs Healthcare

For Patient Monitoring & Connectivity, Anesthesia Delivery and Diagnostic Cardiology Solutions

ISSAQUAH, Wash.--()--Under one of the largest contracts ever received by its Latin America and Caribbean distributor, Spacelabs Healthcare will provide multiple Venezuela hospitals with patient monitoring and connectivity, anesthesia delivery, and diagnostic cardiology solutions. In total, 150 XPREZZON™ and Ultraview SL® patient monitors; as well as 15 Focus and Genius anesthesia systems; and nearly 100 Holter monitoring, ABP and stress test products will be delivered over the next three months. Software connectivity solutions such as the renowned ICS G2 application suite and the Sentinel Cardiology Management System are also included.

“This is testament to Spacelabs’ commitment to providing a wide portfolio of patient care solutions that span patient care areas around the globe,” said Nicholas Ong, President of Spacelabs Healthcare.

Introduced just one year ago, the XPREZZON patient monitor is the first in Spacelabs’ Art of Monitoring portfolio – offering a perfect blend of contemporary design and innovative technology to improve patient care while enhancing the patient and family experience. Most recently, Spacelabs added a fresh new perspective in compact patient monitoring – qube™ – to the product family.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.

Contacts

Spacelabs Healthcare
Glyn Barnes
Mobile: +44 (0)7738 342516
Office: +44 (0)1992 507700
glyn.barnes@spacelabs.com
www.spacelabshealthcare.com

Contacts

Spacelabs Healthcare
Glyn Barnes
Mobile: +44 (0)7738 342516
Office: +44 (0)1992 507700
glyn.barnes@spacelabs.com
www.spacelabshealthcare.com